Levetiracetam-induced gingival hyperplasia

J Postgrad Med. 2022 Jul-Sep;68(3):168-169. doi: 10.4103/jpgm.jpgm_1059_21.

Abstract

Levetiracetam is a new generation antiseizure medication which binds to synaptic vesicle protein SV2A and inhibits the release of neurotransmitters. Gingival hyperplasia is a common side effect of conventional antiseizure medications like phenytoin, but very rare with the newer ones. A 14-year-old boy was started on levetiracetam 250 mg twice daily after a generalized seizure. Five days later he presented with gingival swelling and painful oral aphthae, without lymphadenopathy or systemic symptoms. Blood investigations were normal. After one-month of stopping the drug, the lesions cleared. This case highlights the importance of maintaining good oral hygiene and periodic dental review in patients on antiseizure medications.

Keywords: Anticonvulsants; gingival hyperplasia; levetiracetam.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Anticonvulsants
  • Gingival Hyperplasia*
  • Humans
  • Levetiracetam
  • Male
  • Phenytoin
  • Seizures

Substances

  • Anticonvulsants
  • Levetiracetam
  • Phenytoin